Monday , November 4 2024

Are You a Candidate for Clinical Research?

Are You a Candidate for Clinical Research?Through clinical research studies, doctors may find new and better ways to prevent, detect, diagnose, control, and treat illnesses in the future.
All investigational medicines have to be researched for many years and FDA approved before doctors can prescribe them. Volunteers are very important to this process. Without volunteers, we could not conduct these studies.
The more an investigational drug shows positive signs, the more participants will be added to the study and the research continues to the next phase. Clinical research studies can vary in size from a single center in one country to multi-center studies in multiple countries.
Investigational drug, device, and procedure testing begins with extensive laboratory research which can involve years of experiments. If the initial laboratory research is successful, researchers send the data to the Food and Drug Administration (FDA) for approval to continue research and testing in humans. Once approved, human testing of experimental drugs, devices and procedures can begin and is typically conducted in four phases. Each phase is considered a separate study and, after each phase, investigators are required to submit their data for approval from the FDA before continuing to the next phase.
Who Should Participate?
It is important to test investigational drugs in people with the condition for which the study drug is designed. It is also important to conduct research in a variety of people because different people may respond differently to the study drug. FDA seeks to ensure that people of different ages, races, ethnic groups, and genders are included in clinical research studies.
Some people participate in research studies because they have exhausted approved treatment options – which either did not work for them, or they were unable to tolerate certain side effects. Clinical research studies may provide another option when standard therapy has failed.
Other people participate in research studies because they want to contribute to the advancement of medical knowledge. Not everyone who applies for a clinical research study will be accepted. Volunteers may be excluded based on the eligibility criteria and/or the number of participants needed by the researchers to collect enough information to determine the safety and effectiveness of a medication.
Is Research for Me?
Clinical research studies may provide people with the chance to contribute to the discovery of future, new and improved medications. To be eligible to participate, you must meet the requirements of a particular study. Each study has different requirements. After speaking to one of our patient specialists, you will know if you fit the criteria or not. For a list of our current studies, visit our website.
Current Memory Loss Studies
If you have any of the provided symptoms, please call one of our trained staff to discuss a clinical research study today at 352-877-4039.
Alzheimer’s Disease
Impaired memory and thinking, disorientation and confusion, misplacing things, trouble performing familiar tasks, poor or decreased judgment, or problems with language and communication.
Dementia
Getting lost on familiar routes, language problems such as trouble finding the name of familiar objects, misplacing items, change in sleep patterns, or forgetting about current events.
Memory Loss
Occasional forgetfulness or loss of short-term memory that interferes with daily life.
Mild Cognitive Impairment
Diminished thinking skills, ability to make sound decisions, judge time or space, or forgetting important information that he or she would previously have recalled easily.
To learn more about the memory loss studies or to discover the other types of clinical studies currently being performed, call 352-877-4039 today. Your participation my help mold future treatments for your disease.

Check Also

Weight Loss

Preventing Type 2 Diabetes: The Power of Weight Loss

Type 2 diabetes is a chronic condition affecting millions worldwide, but the good news is …